ATLASVolitionRx (VNRX) earnings date: Nov 12, 2026
VolitionRx (VNRX) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, after the close. Analysts expect EPS of -$0.35.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VNRX
| Last price | $0.21 (+3.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.9% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the VolitionRx stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
VolitionRx reports on Nov 12, 2026. One email the day before, with ATLAS’s read on VolitionRx. You can switch it off at any time.
Alert me before VNRX reportsFree to start. Creating an account takes under a minute.
Notify me when VolitionRx reports
Track VNRX free Add VolitionRx to a free ATLAS watchlist and see its next report date in one place.
VNRX earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.35 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -2.3% |
| Average move around a report | ±9.8% (last 5) |
| Sector | Healthcare · Medical Devices |
VolitionRx earnings history: last 5 reports
VolitionRx last reported on Aug 13, 2026: EPS of -$0.59 against an estimate of -$0.67 (+11.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.67 | -$0.59 | +11.9% | Beat | -19.4% |
| May 28, 2026 | $1.23 | $1.28 | +4.1% | Beat | -9.2% |
| May 14, 2026 | -$0.73 | -$0.97 | -32.9% | Miss | -15.3% |
| Mar 31, 2026 | -$0.80 | -$0.91 | -13.8% | Miss | +5.3% |
| Mar 3, 2026 | $0.21 | $0.25 | +19.1% | Beat | 0.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VNRX
See the fair value, the probability range and the earnings history of VolitionRx on its ATLAS page.
VolitionRx (VNRX) stock analysisPlans from €3.99 a month.
VolitionRx earnings: frequently asked questions
When does VolitionRx (VNRX) report earnings?
VolitionRx is scheduled to report on Thursday, November 12, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VNRX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.35 per share (USD). Estimates can change before the report.
How often does VNRX beat earnings estimates?
Of its last 5 reports with a recorded result, VolitionRx beat the EPS estimate 3 times; the average surprise was -2.3%. Past results do not predict the next one.
How much does VNRX move around earnings?
Over its last 5 reports the stock moved an average of 9.8% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did VolitionRx beat earnings estimates last quarter?
VolitionRx last reported on Aug 13, 2026: EPS of -$0.59 against an estimate of -$0.67 (+11.9% surprise), a beat.
How much does VNRX usually move in a day?
On a normal trading day the ATLAS model puts VNRX’s one-day range at about ±4.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer